Identification and Disclosure of Relationships with External Entities

The NCCN Disclosure Policies and Potential Conflicts of Interest is a comprehensive policy for disclosure of financial relationships and for management of potential conflicts of interest. The disclosure information for all of the Guidelines Panel and NCCN staff is noted below.

 

NCCN Guideline Panels

NCCN Staff

NCCN Clinical Information Staff disclosures are included within the panel lists above.

The following member of the NCCN Senior Management Team has the following relevant financial relationships with ineligible companies to disclose. All of the relevant financial relationships listed for this individual have been mitigated.

Crystal Denlinger, MD, FACP
2seventy bio: Grant/Research Support
AbbVie, Inc.: Grant/Research Support
Bluebird bio: Grant/Research Support
Bristol Myers Squibb: Grant/Research Support
Eli Lilly and Company: Grant/Research Support
Genentech, Inc: Grant/Research Support
GSK: Grant/Research Support
Pfizer Inc: Grant/Research Support
Sanofi: Grant/Research Support

The remaining members of the NCCN Senior Management Team and the NCCN Continuing Education Staff have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.